Single-Site ALK-Positive Histiocytosis With TFG-ALK Fusion: Expanding the Clinical Spectrum of This Rare Entity
American Journal of Case Reports · 15.08.2026 · 27
DOI: 10.12659/ajcr.952807 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, online erschienen am 15.08.2026. Verfasst von Mona Dasgupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Tennessee Medical Center, Knoxville, TN, USA. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Histiocytosis. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Tennessee Medical Center, Knoxville, TN, USA.
- Department of Pathology, University of Tennessee Medical Center, Knoxville, TN, USA.
- Division of Thoracic Surgery, Department of Surgery, University of Tennessee Medical Center, Knoxville, TN, USA.
Zitieren
APA
Dasgupta, M., Horvath, D., Bevill, B., Scheiderer, A., & Jordan, S. (2026). Single-Site ALK-Positive Histiocytosis With TFG-ALK Fusion: Expanding the Clinical Spectrum of This Rare Entity. American Journal of Case Reports, 27. https://doi.org/10.12659/ajcr.952807
Vancouver
Dasgupta M, Horvath D, Bevill B, Scheiderer A, Jordan S. Single-Site ALK-Positive Histiocytosis With TFG-ALK Fusion: Expanding the Clinical Spectrum of This Rare Entity. American Journal of Case Reports. 2026;27. doi:10.12659/ajcr.952807
BibTeX
@article{Dasgupta2026,
author = {Dasgupta, Mona and Horvath, David and Bevill, Benjamin and Scheiderer, Ashley and Jordan, Sean},
title = {Single-Site ALK-Positive Histiocytosis With TFG-ALK Fusion: Expanding the Clinical Spectrum of This Rare Entity},
journal = {American Journal of Case Reports},
year = {2026},
volume = {27},
doi = {10.12659/ajcr.952807}
}
EUVIMED